Want to find out what’s new with VentureWell early-stage innovator teams? Read the VentureWell Startup Roundup! Each month, we’ll share announcements, accomplishments, and other good news from teams in our community.
August Highlights:
- Hazel Technologies Welcomes New Partner AMR Agro
- Abreos Biosciences Launches First Commercial Product
Partnerships & Sales
Hazel Technologies Welcomes New Partner AMR Agro
Hazel Technologies, 2015 E-Team and one of our Investment Portfolio teams, is rising to meet increasing international demand. This past month the company announced a new partnership with Dominican Republic-based AMR Agro—one of the country’s largest green-skin avocado packer and exporters. The partnership will initially focus on one of Hazel’s most recent innovations in post-harvest quality technology: Hazel® Avocado, a small packaging insert that is placed in the box during packing to reduce spoilage. After successful commercial trials with Hazel® Avocado, AMR has adapted its use across a variety of its export programs from the Dominican Republic in order to maintain excellent-quality products with minimal waste during transport.
SFC Fluidics, Inc. Announces Partnership with JDRF to Develop Patch Pump with Open-Protocol Communication
SFC Fluidics, Inc. (SFC), a medical technology company and 2016 I-Corps at NIH Team, announced a new Industry Discovery and Development Partnership supported by JDRF, the leading global organization funding type 1 diabetes (T1D) research. JDRF will provide funding to SFC for the development of an insulin patch pump with open-protocol communication capabilities.
Technology Breakthroughs
Abreos Biosciences Launches First Commercial Product
Abreos Biosciences, 2014 I-Corps at NIH Team and leader in the precision dosing of biological therapeutics, announced the launch of its first commercial product, moNATor. The product is a laboratory developed test (LDT) used to aid physicians in the monitoring of Tysabri (natalizumab), an immunosuppressive drug, in patients with multiple sclerosis and help guide decision making regarding optimal dosing intervals.
Akadeum Life Sciences Announces New Microbubble Products will be Commercially Available
Akadeum Life Sciences, Inc., a 2014 NSF I-Corps team, announced early access to its microbubble-based T cell and B cell isolation kits. A radical simplification of existing technologies, the use of microbubbles enables users to perform the entire cell separation process within a single tube and without a magnet. The company has recently completed a beta testing program where key opinion leaders from across the US performed testing and provided feedback, and will be offering an “Early Access Program” before their full commercial launch.